Solving the 'What Next' Problem in Health Diagnostics: Interview with Vero Bioscience CEO Paul Coletta

In this episode, we sat down with Paul Coletta, the co-founder and CEO of Vero Bioscience. Vero's OrganAge™ assay measures the biological age of each organ from a single blood draw, and its Vero Compass platform turns that reading into a targeted action plan.  Paul built his career on storytelling and consumer marketing, starting with a decade at Disney before leading brand and product marketing roles at MTV Networks, Nickelodeon, and Hewlett-Packard. He then went on to build popular food brands including Jamba Juice and Pinkberry, and spent a decade as CEO and Chairman of Urban Remedy. In this interview, Paul explains why scientific validation isn't enough to bring a diagnostic to market. He also shares how Vero closed a $6 million seed round in just three weeks, what "patriots, not mercenaries" means when building a team, and the difference between asking a board for advice versus asking for permission. If you'd rather read the summary of Paul’s episode, head over here.